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Abstract
The lung is constantly exposed to the environment and its microbial components. Infections of the
respiratory tract are amongst the most common diseases. Several concepts describe how this
microbial exposure interacts with allergic airway disease as it is found in patients with asthma.
Infections are classical triggers of asthma exacerbations. In contrast, the hygiene hypothesis offers
an explanation for the increase in allergic diseases by establishing a connection between microbial
exposure during childhood and the risk of developing asthma. This premise states that the
microbial environment interacts with the innate immune system and that this interrelation is
needed for the fine-tuning of the overall immune response. Based on the observed protective effect
of farming environments against asthma, animal models have been developed to determine the
effect of specific bacterial stimuli on the development of allergic inflammation. A variety of studies
have shown a protective effect of bacterial products in allergen-induced lung inflammation.
Conversely, recent studies have also shown that allergic inflammation inhibits antimicrobial host
defense and renders animals more susceptible to bacterial infections. This paper focuses on
examples of animal models of allergic disease that deal with the complex interactions of the innate
and adaptive immune system and microbial stressors.
The lung is constantly exposed to the environment and its
microbial components. Infections of the respiratory tract
are amongst the most common diseases. Several concepts
describe how this microbial exposure interacts with aller-
gic airway disease as it is found in patients with asthma.
Infections are classical triggers of asthma exacerbations.
Infections of the respiratory tract, especially with various
viruses, are common causes of exacerbation of asthma
[1,2].
The hygiene hypothesis offers an explanation for rising
rates of allergic diseases such as asthma in modern west-
ernized societies. The core of this hypothesis is the com-
plex interaction of the microbial environment and the
innate immune system in the childhood of individuals. In
modern societies, different factors such as small family
size, high antibiotics use, and good sanitation contribute
to higher living standards and life expectancy [3]. As a
result, regulatory mechanisms that are activated by the
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interaction with the microbial environment and that are
needed to balance the adaptive immune response might
be disturbed. Hygienic environments typical for modern
societies might lack the stimuli that are needed to adjust
the Th1 and Th2 cell mediated adaptive immune
responses finally resulting in an increased prevalence for
both Th1-mediated and Th2-mediated diseases [4].
The observed protective effect of farming environments in
connection with environmental exposure to endotoxin
may have a crucial role in the development of tolerance to
ubiquitous allergens found in natural environments
against asthma [5]. This observation led to the develop-
ment of animal models to determine the effect of specific
bacterial stimuli on the development of allergic inflam-
mation. For instance, several studies have shown a protec-
tive effect of TLR9 agonist on allergic inflammation of the
respiratory tract. Activation of TLR9 promoted the devel-
opment of Th1 cell response in vitro and in vivo. Treat-
ment with TLR9 agonists inhibited the development of
airway hyperresponsiveness, mucus production, and air-
way eosinophil infiltration in mouse asthma models
[6,7]. Furthermore, another study using a murine model
of asthma showed that interperitonal administration of a
synthetic TLR2 ligand ameliorates established allergic air-
way inflammation [8]. The authors claimed that the key
therapeutic approach is to achieve a balance between Th2
and Th1 cytokines by decreasing Th2 cytokines without a
large increase in Th1 response. In addition to TLR2 ago-
nists, animal studies have also demonstrated that LPS sig-
nalling suppresses allergic inflammation of the
respiratory tract. Effects of LPS were mediated by TLR4 [9]
and were independent of IL-12 production by dendritic
cells [10].
In the last years, it has become clear that the appropriate
bacterial composition of the human microflora is a factor
in protection from allergy and asthma and is needed for
an adequate Th1 / Th2 balance [11]. Interestingly, in a
mouse model of asthma, oral treatment with probiotic
organisms inhibited the allergic response in a TLR9
dependent manner [12]. Oral treatment with live Lactoba-
cillus reuteri attenuated the influx of eosinophils into the
respiratory tract and was accompanied by levels of Th2
cytokines.
The studies outlined above deal with the impact of bacte-
rial stressors that preferentially promote a Th1 cell medi-
ated response on the development of Th2 mediated
allergic disease such as asthma. Conversely, a largely
unknown field is the influence of established allergic dis-
eases on infectious diseases that require an appropriate
innate or Th1 cell mediated immune response.
A recent study investigated the effect of an established
allergic inflammation of the lung on the innate host
defense during bacterial infection of the respiratory tract
[13]. The main finding was that the adaptive immune sys-
tem modulates the functions of the pulmonary innate
immune system and that allergic inflammation of the
lung inhibits pulmonary antimicrobial host defense. Tak-
ing advantage of an animal model of allergic airway dis-
ease, it was shown that Th2-type inflammation in the lung
results in a suppressed antibacterial host defense after
infection with Pseudomonas aeruginosa. Mice with allergic
airway inflammation had more viable bacteria and
reduced levels of pro-inflammatory cytokines and antimi-
crobial peptides in their lung. Furthermore, the influx of
neutrophils into the respiratory tract was significantly
diminished in asthmatic animals.
The suppressive effect of the Th2 milieu was also shown in
an in vitro model using differentiated human airway epi-
thelia tissue [13]. The Th2 cytokines IL-4 and IL-13
showed an inhibitory effect on the antimicrobial activity
of the airway epithelium, as airway epithelial cells were
unable to kill bacteria when incubated with these
cytokines. This inhibitory effect was accompanied by a
reduction in expression of the antimicrobial peptide
human  β-defensin 2. These results are consistent with
studies showing that the cytokine milieu of atopic derma-
titis prevents induction of innate immune response fac-
tors such as antimicrobial peptides, IL-8 and iNos.
Additionally, a higher susceptibility of patients with
atopic dermatitis to skin infections was observed [14,15].
However, the exact mechanism how the Th2 milieu inhib-
its the antimicrobial host defense is not clear yet. Interest-
ingly, it has been demonstrated that Th2 cytokines inhibit
the TNF-α/NF-κB system through activation of STAT6
which acts as a transcriptional inhibitor of NF-κB-depend-
ent gene expression [16]. Given that many genes induced
during the innate immune response are under control of
NF-κB, inhibition of NF-κB signalling by Th2 cytokines
could explain the suppressed innate immune response to
bacterial infection in presence of an allergic inflamma-
tion. A complete understanding of how Th2 cytokines
suppress antimicrobial activity of the epithelial cells
remains to be determined.
These results provide evidence that the adaptive immune
system closely interacts with the innate immune system
and that the adaptive immune response influences the
innate host defense (Figure 1). The Th2-dependent sup-
pression of the pulmonary innate immune system could
result in increased susceptibility to colonization and
infection. Chronic colonization could be a risk factor for
asthmatic lung disease. For instance, patients with asthma
are often chronically colonized with Mycoplasma and
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Conclusion
The development of allergic diseases is a complex process.
In recent years, it became clear that the interaction of the
microbial environment with the innate and adaptive
immune system during childhood is crucial for a well bal-
anced immune system. The combination of animal mod-
els of allergic disease with infection models is a useful tool
to further study the interactions between these processes
and is a starting point for new therapeutic strategies.
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Exposure of the lung with microorganisms modulates allergic  airway inflammation in several ways. Inversely, allergic airway  inflammation impacts on host defense. The association of  decreased host defense in asthma with increased susceptibil- ity to colonization with specific microorganisms might fur- ther contribute to disease development Figure 1
Exposure of the lung with microorganisms modulates allergic 
airway inflammation in several ways. Inversely, allergic airway 
inflammation impacts on host defense. The association of 
decreased host defense in asthma with increased susceptibil-
ity to colonization with specific microorganisms might fur-
ther contribute to disease development.